Omana, Edelyn P.

HRN: 01-85-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/05/2024
CEFUROXIME 1.5GM (VIAL)
04/05/2024
04/12/2024
IVT
1.5gm
On Call To OR Then Q 8 Hrs
Diagnostic Curettage
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Urinary TractReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: